Adult Tetanus
Conditions
Interventions
Stedutazumab group:N
Traditional tetanus immunoglobulin group:N
Sponsors
Lianzhou People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. The age is over 18 years old on the day of enrollment, 2. Provide valid identity certificates for me; 3. The ability to understand the research requirements and processes and agree to participate in clinical trials, and sign informed consent; 4. The ability to understand the research procedures and participate in all plans for follow-up; 5. Women are not pregnant or breastfeeding; 6. Those diagnosed as needing acute prevention of tetanus by doctors according to diagnosis and treatment guidelines.
Exclusion criteria
Exclusion criteria: 1. Women in pregnancy or breastfeeding, or women with fertility plans in the first three months of the study; 2. Those who have been clearly infected with tetanus; 3. They have received tetanus vaccine, tetanus-diphtheria combined vaccine within 5 years, or polysaccharide-binding vaccine with TT as carrier protein; 4. They have received other study drugs within 3 months of receiving the vaccine in this study;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Antitetanus neutralizing antibody levels; | — |
Countries
China
Contacts
Public ContactZhejun Tan
Lianzhou People's Hospital
Outcome results
None listed